Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease

Gastroenterology

Volumn 140, Issue 4, 2011, Pages 1189-1198.e1

  Weiss, Karl Heinz ^a   Gotthardt, Daniel Nils ^a   Klemm, Daniela ^a   Merle, Uta ^a   Ferencifoerster, Daniela ^b   Schaefer, Mark ^a   Ferenci, Peter ^b   Stremmel, Wolfgang ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

ATP7B; d penicillamine; Trientine; Triethylenetetramine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COPPER; GAMMA GLUTAMYLTRANSFERASE; PENICILLAMINE; TRIENTINE; ZINC;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHELATION THERAPY; COHORT ANALYSIS; DETERIORATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL; TREATMENT OUTCOME; WILSON DISEASE;

EID: 79953166064     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.12.034     Document Type: Article

References (40)

1. A. Ala, A.P. Walker, and K. Ashkan Wilson's disease Lancet 369 2007 397 408 (Pubitemid 46177228)
2. J.D. Gitlin Wilson disease Gastroenterology 125 2003 1868 1877 (Pubitemid 37500450)
3. P. Ferenci, K. Caca, and G. Loudianos Diagnosis and phenotypic classification of Wilson disease Liver Int 23 2003 139 142 (Pubitemid 37265785)
4. A. Dhawan, R.M. Taylor, and P. Cheeseman Wilson's disease in children: 37-year experience and revised King's score for liver transplantation Liver Transpl 11 2005 441 448 (Pubitemid 40533213)
5. J. Petrasek, M. Jirsa, and J. Sperl Revised King's College score for liver transplantation in adult patients with Wilson's disease Liver Transpl 13 2007 55 61 (Pubitemid 46099974)
6. H. Nazer, R.J. Ede, and A.P. Mowat Wilson's disease: clinical presentation and use of prognostic index Gut 27 1986 1377 1381 (Pubitemid 17175689)
7. E.A. Roberts, and M.L. Schilsky Diagnosis and treatment of Wilson disease: an update Hepatology 47 2008 2089 2111 (Pubitemid 351945575)
8. G.J. Brewer, G.M. Hill, and A.S. Prasad Oral zinc therapy for Wilson's disease Ann Intern Med 99 1983 314 319
9. T.U. Hoogenraad, R. Koevoet, and E.G. de Ruyter Korver Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration) Eur Neurol 18 1979 205 211 (Pubitemid 9237779)
10. G.M. Hill, G.J. Brewer, and A.S. Prasad Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens Hepatology 7 1987 522 528 (Pubitemid 17073159)
11. R.J. Cousins Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin Physiol Rev 65 1985 238 309 (Pubitemid 15081126)
12. I.H. Scheinberg, M.E. Jaffe, and I. Sternlieb The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease N Engl J Med 317 1987 209 213 (Pubitemid 17103102)
13. J.M. Walshe, and A.K. Dixon Dangers of non-compliance in Wilson's disease Lancet 1 1986 845 847 (Pubitemid 16128959)
14. J.M. Walshe Wilson's disease; new oral therapy Lancet 270 1956 25 26
15. J.M. Walshe Copper chelation in patients with Wilson's disease A comparison of penicillamine and triethylene tetramine dihydrochloride Q J Med 42 1973 441 452
16. R.J. Grand, and G.F. Vawter Juvenile Wilson disease: histologic and functional studies during penicillamine therapy J Pediatr 87 1975 1161 1170
17. J.Y. Lau, C.L. Lai, and P.C. Wu Wilson's disease: 35 years' experience Q J Med 75 1990 597 605 (Pubitemid 20214393)
18. A. Czlonkowska, J. Gajda, and M. Rodo Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate J Neurol 243 1996 269 273 (Pubitemid 26071990)
19. R.S. Dubois, D.O. Rodgerson, and K.M. Hambidge Treatment of Wilson's disease with triethylene tetramine hydrochloride (trientine) J Pediatr Gastroenterol Nutr 10 1990 77 81 (Pubitemid 20018112)
20. H. Saito, K. Watanabe, and M. Sahara Triethylene-tetramine (trien) therapy for Wilson's disease Tohoku J Exp Med 164 1991 29 35
21. G.J. Brewer, V. Yuzbasiyan-Gurkan, and D.Y. Lee Treatment of Wilson's disease with zinc. VI. Initial treatment studies J Lab Clin Med 114 1989 633 638 (Pubitemid 20018040)
22. J.M. Walshe Diagnosis and treatment of presymptomatic Wilson's disease Lancet 2 1988 435 437
23. F.H. Linn, R.H. Houwen, and J. van Hattum Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients Hepatology 50 2009 1442 1452
24. T.U. Hoogenraad, J. Van Hattum, and C.J. Van den Hamer Management of Wilson's disease with zinc sulphate Experience in a series of 27 patients J Neurol Sci 77 1987 137 146 (Pubitemid 17231288)
25. G.J. Brewer, R.D. Dick, and V.D. Johnson Treatment of Wilson's disease with zinc: XV long-term follow-up studies J Lab Clin Med 132 1998 264 278 (Pubitemid 28490259)
26. J.M. Walshe, and N.A. Munro Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet Arch Neurol 52 1995 10 11
27. C.J. Lang, P. Rabas-Kolominsky, and A. Engelhardt Fatal deterioration of Wilson's disease after institution of oral zinc therapy Arch Neurol 50 1993 1007 1008 (Pubitemid 23301243)
28. E.E. Santos Silva, J. Sarles, and J.P. Buts Successful medical treatment of severely decompensated Wilson disease J Pediatr 128 1996 285 287 (Pubitemid 26065962)
29. F.K. Askari, J. Greenson, and R.D. Dick Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc J Lab Clin Med 142 2003 385 390 (Pubitemid 38102022)
30. V. Medici, C.P. Trevisan, and R. D'Inca Diagnosis and management of Wilson's disease: results of a single center experience J Clin Gastroenterol 40 2006 936 941 (Pubitemid 44690770)
31. J.M. Walshe Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients Q J Med 70 1989 253 263 (Pubitemid 19135600)
32. K.H. Weiss, U. Merle, and M. Schaefer Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels World J Gastroenterol 12 2006 2239 2242
33. K.H. Weiss, H. Runz, and B. Noe Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease J Inherit Metab Dis 2010 Jun 2 [Epub ahead of print]
34. M.T. Pellecchia, C. Criscuolo, and K. Longo Clinical presentation and treatment of Wilson's disease: a single-centre experience Eur Neurol 50 2003 48 52 (Pubitemid 36736969)
35. A.B. Taly, S. Meenakshi-Sundaram, and S. Sinha Wilson disease: description of 282 patients evaluated over 3 decades Medicine (Baltimore) 86 2007 112 121 (Pubitemid 46668060)
36. I. Shimon, B. Moses, and B.A. Sela Hemolytic episode in a patient with Wilson's disease treated with zinc Isr J Med Sci 29 1993 646 647 (Pubitemid 23301402)
37. G.J. Brewer, G.M. Hill, and R.D. Dick Treatment of Wilson's disease with zinc: III Prevention of reaccumulation of hepatic copper J Lab Clin Med 109 1987 526 531 (Pubitemid 17074016)
38. G.J. Brewer, V. Yuzbasiyan-Gurkan, and V. Johnson Treatment of Wilson's disease with zinc XII: dose regimen requirements Am J Med Sci 305 1993 199 202 (Pubitemid 23124747)
39. J.M. Walshe, and M. Yealland Chelation treatment of neurological Wilson's disease Q J Med 86 1993 197 204 (Pubitemid 23120815)
40. G.J. Brewer, C.A. Terry, and A.M. Aisen Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy Arch Neurol 44 1987 490 493 (Pubitemid 17061929)